Number and percentage of chronic comorbidities (as elaborated in the supplementary material) at the time of sleep apnoea diagnosis for all those diagnosed with sleep apnoea in Finland in 2017
| Men (n=16 263) | Women (n=9061) | ||||
| Cases (n) | Prevalence (%) | Cases (n) | Prevalence (%) | p-value | |
| Cancer | 871 | 5.36 | 536 | 5.92 | 0.070 |
| Kidney and urinary tract disease | 555 | 3.41 | 232 | 2.56 | <0.001 |
| Thyroid disease | 337 | 2.07 | 891 | 9.83 | <0.001 |
| Other metabolic disease | 563 | 3.46 | 552 | 6.09 | <0.001 |
| Diabetes | 3324 | 20.44 | 1705 | 18.82 | 0.006 |
| Obesity | 1053 | 6.47 | 1053 | 11.62 | <0.001 |
| Gastro-oesophageal reflux disease | 311 | 1.91 | 335 | 3.70 | <0.001 |
| Dementia and other cerebral disorders | 703 | 4.32 | 291 | 3.21 | <0.001 |
| Schizophrenia and delusional disorders | 215 | 1.32 | 141 | 1.56 | 0.133 |
| Mood and neurotic disorders | 1606 | 9.88 | 1746 | 19.27 | <0.001 |
| Nonorganic sleep disorders | 355 | 2.18 | 335 | 3.70 | <0.001 |
| Neurological disorders | 1221 | 7.51 | 1232 | 13.60 | <0.001 |
| Glaucoma | 234 | 1.44 | 193 | 2.13 | <0.001 |
| Hypertension | 4217 | 25.93 | 2752 | 30.37 | <0.001 |
| Cardiovascular disease | 3757 | 23.10 | 2202 | 24.30 | 0.059 |
| Atrial fibrillation | 1496 | 9.20 | 634 | 7.00 | <0.001 |
| Other respiratory disease | 1653 | 10.16 | 1311 | 14.47 | <0.001 |
| Gastrointestinal disease | 2671 | 16.42 | 2065 | 22.79 | <0.001 |
| Musculoskeletal disease | 5797 | 35.65 | 4717 | 52.06 | <0.001 |
| Urogenital disease | 1440 | 8.85 | 206 | 2.27 | <0.001 |
| Heart failure | 624 | 3.84 | 319 | 3.52 | <0.001 |
| Cerebrovascular disease | 532 | 3.27 | 296 | 3.27 | 0.211 |
| Organic sleep disorders | 197 | 1.21 | 175 | 1.93 | 0.985 |
| Asthma | 967 | 5.94 | 1137 | 12.55 | <0.001 |
| COPD | 572 | 3.52 | 293 | 3.23 | 0.744 |
| Dyslipidaemia | 1745 | 10.73 | 985 | 10.87 | 0.242 |